🇫🇷
France · FR · FR:65889825
BRIMONIDINE SANDOZ 0,2 % (2 mg/ml), collyre en solution
ReimbursedATC S01GA07
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerSANDOZ
CountryFR (France)
ATC codeS01GA07
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009393088691 flacon(s) compte-gouttes polyéthylène basse densité (PEBD) de 5 mlEUR 3.55
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "65889825",
"date_amm": "2009-03-20",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code S01GA07.
- GBAlphagan 0.2% eye dropsLexon (UK) Ltd
- GBAlphagan 0.2% eye dropsMawdsley-Brooks & Company Ltd
- GBAlphagan 0.2% eye dropsDowelhurst Ltd
- GBAlphagan 0.2% eye dropsSigma Pharmaceuticals Plc
- GBAlphagan 0.2% eye dropsAbbVie Ltd
- GBAlphagan 0.2% eye dropsDE Pharmaceuticals
- GBAlphagan 0.2% eye dropsWaymade Healthcare Plc
- GBAlphagan 0.2% eye dropsNecessity Supplies Ltd
Access this data programmatically
Query BRIMONIDINE SANDOZ 0,2 % (2 mg/ml), collyre en solution and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.